1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double- blind placebo-controlled trial

MLA

Bolhuis, T. E., et al. “1-Year Results of Treatment with Rituximab in Polymyalgia Rheumatica: An Extension Study of a Randomised Double- Blind Placebo-Controlled Trial.” The Lancet. Rheumatology, 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1376266341&authtype=sso&custid=ns315887.

APA

Bolhuis, T. E., Marsman, D. E., Broeder, A. A. den, Broeder, N. den, & Maas, A. van der. (2023). 1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double- blind placebo-controlled trial. The Lancet. Rheumatology.

Chicago

Bolhuis, T.E., Diane E. Marsman, A.A. den Broeder, N. den Broeder, and A. van der Maas. 2023. “1-Year Results of Treatment with Rituximab in Polymyalgia Rheumatica: An Extension Study of a Randomised Double- Blind Placebo-Controlled Trial.” The Lancet. Rheumatology. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1376266341&authtype=sso&custid=ns315887.